{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:08:33Z","timestamp":1775477313690,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005155","name":"Azrieli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.parkreldis.2019.05.010","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T18:07:03Z","timestamp":1557338823000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The spectrum of tremor among carriers of the FMR1 premutation with or without the fragile X-associated tremor\/ataxia syndrome (FXTAS)"],"prefix":"10.1016","volume":"65","author":[{"given":"Tsviya","family":"Fay-Karmon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Hassin-Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.05.010_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/374321","article-title":"Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates","volume":"72","author":"Jacquemont","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21493","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines","volume":"22","author":"Berry-Kravis","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajmg.a.31559","article-title":"Neuropathic features in fragile X premutation carriers","volume":"143","author":"Berry-Kravis","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mds.20753","article-title":"Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical-pathological study","volume":"21","author":"Louis","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2310\/JIM.0b013e3181af59c4","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical phenotype, diagnosis, and treatment","volume":"57","author":"Leehey","year":"2009","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1176\/jnp.2006.18.2.171","article-title":"Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor\/ataxia syndrome: clinical intervention with donepezil and venlafaxine","volume":"18","author":"Bourgeois","year":"2006","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mds.21252","article-title":"Progression of tremor and ataxia in male carriers of the FMR1 premutation","volume":"22","author":"Leehey","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","article-title":"Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"69","author":"Adams","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib11","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"New insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib12","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/brain\/awf184","article-title":"Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers","volume":"125","author":"Greco","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1601-183X.2012.00779.x","article-title":"Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS","volume":"11","author":"Tassone","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ajmg.b.32065","article-title":"Prevalence of CGG expansions of the FMR1 gene in a US population-based sample","volume":"159 B","author":"Seltzer","year":"2012","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1399-0004.2010.01448.x","article-title":"Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome","volume":"78","author":"Chonchaiya","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation","volume":"146","author":"Coffey","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib17","series-title":"The Fragile X-Associated Tremor Ataxia Syndrome","author":"Tassone","year":"2010"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ajmg.b.30482","article-title":"CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"144","author":"Tassone","year":"2007","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/13854046.2016.1202239","article-title":"Fragile X-associated tremor\/ataxia syndrome: phenotypic comparisons with other movement disorders","volume":"30","author":"Robertson","year":"2016","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ana.10522","article-title":"Tremor and ataxia in fragile X premutation carriers: blinded videotape study","volume":"53","author":"Berry-Kravis","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10048-010-0270-5","article-title":"New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS)","volume":"12","author":"Juncos","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib24","series-title":"Clinical Rating Scale for Tremor, in: Park. Dis. Mov. Disord.","first-page":"225","author":"Fahn","year":"1988"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1352\/0895-8017(2004)109<154:AIIWTF>2.0.CO;2","article-title":"Aging in individuals with the FMR1 mutation","volume":"109","author":"Jacquemont","year":"2004","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.wnl.0000281692.98200.f5","article-title":"FMR1 CGG repeat length predicts motor dysfunction in premutation carriers","volume":"70","author":"Leehey","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.parkreldis.2014.01.006","article-title":"Parkinsonism in fragile X-associated tremor\/ataxia syndrome (FXTAS): revisited","volume":"20","author":"Niu","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.parkreldis.2008.04.037","article-title":"Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease","volume":"15","author":"Hall","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00415-007-0711-8","article-title":"MRI and SPECT of midbrain and striatal degeneration in fragile X-associated tremor\/ataxia syndrome [10]","volume":"255","author":"Scaglione","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jnnp-2014-309460","article-title":"Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases","volume":"86","author":"De Pablo-Fernandez","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2014.11.058","article-title":"Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor\/ataxia syndrome","volume":"1598","author":"Ariza","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib32","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/hmg\/ddr211","article-title":"Altered zinc transport disrupts mitochondrial protein processing\/import in fragile X-associated tremor\/ataxia syndrome","volume":"20","author":"Napoli","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/BJ20091960","article-title":"Evidence of mitochondrial dysfunction in fragile X-associated tremor\/ataxia syndrome","volume":"429","author":"Ross-Inta","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0891988706297737","article-title":"FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal study","volume":"20","author":"Kurz","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2010.12.013","article-title":"Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease","author":"Costa","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/01.wnl.0000168900.86323.9c","article-title":"Initial diagnoses given to persons with the fragile X associated tremor\/ataxia syndrome (FXTAS)","volume":"65","author":"Hall","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/mds.20043","article-title":"Screen for expanded FMR1 alleles in patients with essential tremor","volume":"19","author":"Garcia Arocena","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2015.03.027","article-title":"Genetic analysis of FMR1 repeat expansion in essential tremor","volume":"593","author":"Clark","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awh535","article-title":"The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group","volume":"128","author":"Kamm","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib40","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/mds.21001","article-title":"Symptomatic treatment in the fragile X-associated tremor\/ataxia syndrome","volume":"21","author":"Hall","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/WNF.0b013e31816a48e2","article-title":"Levetiracetam improves intention tremor in fragile x-associated tremor\/ataxia syndrome","volume":"32","author":"Saponara","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib42","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.13m08546","article-title":"Memantine for fragile x-associated tremor\/ataxia syndrome: a randomized, double-blind, placebo-controlled trial","author":"Seritan","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib43","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1002\/mds.20071","article-title":"New therapeutic indications for botulinum toxins","volume":"19","author":"Cordivari","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/CIA.S1794","article-title":"Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems","volume":"3","author":"Hagerman","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0000000000000016","article-title":"(medical marijuana) treatment for motor and non-motor symptoms of P. disease: an open-label observational study. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parki","volume":"37","author":"Lotan","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib46","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mds.20111","article-title":"Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms","volume":"19","author":"Venderov\u00e1","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-017-0555-6","article-title":"Open-label allopregnanolone treatment of men with fragile X-associated tremor\/ataxia syndrome","author":"Wang","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archneur.60.1.117","article-title":"The fragile X premutation presenting as essential tremor","volume":"60","author":"Leehey","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib49","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/brain\/aww223","article-title":"Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?","volume":"139","author":"Reich","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMoa1600159","article-title":"A randomized trial of focused ultrasound thalamotomy for essential tremor","volume":"375","author":"Elias","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jnnp-2014-307642","article-title":"Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes","volume":"86","author":"Chang","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib52","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1300962","article-title":"A pilot study of focused ultrasound thalamotomy for essential tremor","volume":"369","author":"Elias","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1474-4422(13)70048-6","article-title":"MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study","volume":"12","author":"Lipsman","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.parkreldis.2016.04.002","article-title":"A single Case report of MR-guided focused ultrasound thalamotomy for tremor in fragile X-associated tremor\/ataxia","volume":"28","author":"Cerquera","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib55","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0000000000002982","article-title":"MRI-guided focused ultrasound thalamotomy in fragile X-Associated tremor\/ataxia syndrome","volume":"87","author":"Fasano","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.010_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00512","article-title":"Making a difference\u2014positive effect of unilateral VIM Gamma Knife thalamotomy in the therapy of tremor in fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"9","author":"Alster","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.010_bib57","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S1474-4422(13)70125-X","article-title":"Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor\/ataxia syndrome","volume":"12","author":"Hagerman","year":"2013","journal-title":"Lancet Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:18:18Z","timestamp":1761178698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019302317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":57,"alternative-id":["S1353802019302317"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.010","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of tremor among carriers of the FMR1 premutation with or without the fragile X-associated tremor\/ataxia syndrome (FXTAS)","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}